Thursday August 21, 2008
Articles in Prominent Medical Journal Doubt Worth and Benefit of HPV Vaccines
By Tim Waggoner
WASHINGTON, August 21, 2008 (LifeSiteNews.com) – The New England Journal of Medicine posted two articles this week that asked why two human papillomavirus vaccines have been so widely distributed given their unproven effectiveness and high costs.
Gardasil by Merck Sharp & Dohme, which has already received tremendous criticism for the severe and fatal side-effects experienced by users, and Cervarix by GlaxoSmithKline were the two drugs called to question.
As reported by the New York Times, Dr. Charlotte J. Haug, editor of The Journal of the Norwegian Medical Association, whose editorial appeared in Thursday's issue of The New England Journal, said, "Despite great expectations and promising results of clinical trials, we still lack sufficient evidence of an effective vaccine against cervical cancer. With so many essential questions still unanswered, there is good reason to be cautious."
Both vaccines were tested for relatively short periods of time, revealed Dr. Haug, and researchers are yet to prove whether or not the vaccines offer lasting immunity and if a user's natural immunity to other strains not eliminated by the vaccines will be compromised. Dr. Haug said it is not certain if the protection offered by the vaccines will even lead to reduced rates of cervical cancer.
Jane J. Kim and Dr. Sue Goldie of Harvard, who likewise had a study published in this week's issue of the medical journal, also brought up the fact that the vaccines have not been proven to offer life-long protection. They said that until this is certain, the cost of the vaccines cannot be justified.
Furthermore, the costs of the vaccines cannot be offset by eliminating Pap smear screening because the test is still needed to identify HPV strands that the vaccines do not protect against.
These studies criticizing the effectiveness and cost of the HPV vaccines could not come at worse time for Merck – the drug giant is under fire because of a reported 9,749 cases of severe side-effects and 21 deaths associated with Gardasil.
See related LifeSiteNews.com coverage:
HPV Vaccine Causes 21 Deaths and Counting - CDC Study Launched
http://www.lifesitenews.com/ldn/2008/aug/08081405.html
Latest Headlines
- Cardinal George Denounces "New Ways Ministry" as Pseudo-Catholic Organization

- Irony: 19-Child Duggar Family Renting Former Home of Local Planned Parenthood Leader

- Document Reveals Inconsistencies in ND's Jenkins Claims on ND88

- New Country Music Star Born as Pro-Life Ballad Climbs the Charts

- Future of Pontifical Academy for Life at Stake as Members Meet in Closed Door Session

- Rally Planned in Defence of Canadian Pro-Life Ad

- Commentary on February 8 News

- Chinese Human-Rights Crusaders Nominated for Nobel Peace Prize

- U.K.’s Conservative Leader Pledges Full Support to Gay Agenda

- B.C. Civil Liberties Association Goes to Bat for Pro-Life Student Club

- Police Refuse to Release Federal "Threat Assessment" on Wis. Pro-Lifers

- Canadian Human Rights Commission Appeals Ruling against Hate Messages Statute

- Homosexual Activist Keith Norton Dies at 69

- Malta Celebrates 32nd Pro-Life Day

- My Vote for Best Pro-life Super Bowl Ad: Google’s Parisian Love Story

- Pope: Family Necessary for Child Development

- Letters to the Editor

Most Read this Week
- Veterans, Former Army Legal Chief Defend “Don’t Ask, Don’t Tell”
- Planned Parenthood President Lands Spot on Ford Foundation Board
- Rabbis Warn against 'Disaster' of Open Homosexuality in the Military
- Football Pros Give Support to Tim Tebow Super Bowl Ad
- Clash of the Abortion Titans: Planned Parenthood Launches 'Pro-Choice' Football Ad
- Canadian Station Pulls Pro-Life Ad – Too “Graphic”
- Hijacking the Brain — How Pornography Works
- Group Exposes Media "Fraud" at March for Life
- U.S. Sisters in Crisis after Embracing “Secular Culture”: Vatican Cardinal
- NYT: Rampant Polygamy in Gay 'Marriage' May Benefit Institution
MORE NEWS:
LifeSiteNews.com Home Page
Last 10 Days
Archives
Special Reports
Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.








Back to Top